Richard Mayeux

Author PubWeight™ 284.36‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011 24.26
2 Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med 2012 14.14
3 Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet 2011 10.07
4 The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet 2007 9.80
5 Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet 2010 5.52
6 Apolipoprotein E, Alzheimer disease, and African Americans. Arch Neurol 2003 4.63
7 Mediterranean diet and risk for Alzheimer's disease. Ann Neurol 2006 4.38
8 Epidemiology of Alzheimer disease. Nat Rev Neurol 2011 4.13
9 Hypertension and the risk of mild cognitive impairment. Arch Neurol 2007 3.62
10 A summary risk score for the prediction of Alzheimer disease in elderly persons. Arch Neurol 2010 3.52
11 Stroke and the risk of Alzheimer disease. Arch Neurol 2003 3.49
12 Mediterranean diet and mild cognitive impairment. Arch Neurol 2009 3.40
13 Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol 2008 3.39
14 Imaging hippocampal function across the human life span: is memory decline normal or not? Ann Neurol 2002 3.34
15 Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families. PLoS One 2012 3.11
16 Mediterranean diet, Alzheimer disease, and vascular mediation. Arch Neurol 2006 2.98
17 Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol 2010 2.91
18 Alcohol intake and risk of dementia. J Am Geriatr Soc 2004 2.90
19 Pilot association study of the beta-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity. Mov Disord 2005 2.88
20 Hyperinsulinemia and risk of Alzheimer disease. Neurology 2004 2.87
21 Relation of diabetes to mild cognitive impairment. Arch Neurol 2007 2.86
22 Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center. Neurology 2005 2.76
23 Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan. Arch Neurol 2008 2.69
24 Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans. JAMA 2013 2.58
25 Mediterranean diet and Alzheimer disease mortality. Neurology 2007 2.45
26 Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community. Arch Neurol 2005 2.39
27 Caloric intake and the risk of Alzheimer disease. Arch Neurol 2002 2.28
28 Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants. PLoS Genet 2012 2.23
29 The association between genetic variants in SORL1 and Alzheimer disease in an urban, multiethnic, community-based cohort. Arch Neurol 2007 2.21
30 Shorter telomeres are associated with mortality in those with APOE epsilon4 and dementia. Ann Neurol 2006 2.21
31 Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2. Ann Neurol 2012 2.20
32 Antioxidant vitamin intake and risk of Alzheimer disease. Arch Neurol 2003 2.20
33 GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease. Neuron 2013 2.13
34 Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neurol 2004 2.09
35 Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology 2012 2.08
36 Association of glucocerebrosidase mutations with dementia with lewy bodies. Arch Neurol 2009 2.06
37 Validity of self-reported stroke in elderly African Americans, Caribbean Hispanics, and Whites. Arch Neurol 2009 2.05
38 Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE. PLoS Genet 2011 2.02
39 SORCS1 alters amyloid precursor protein processing and variants may increase Alzheimer's disease risk. Ann Neurol 2011 2.01
40 Cardiovascular risk factors and Alzheimer's disease. Curr Atheroscler Rep 2004 2.00
41 Comprehensive search for Alzheimer disease susceptibility loci in the APOE region. Arch Neurol 2012 1.97
42 The brain in the age of old: the hippocampal formation is targeted differentially by diseases of late life. Ann Neurol 2008 1.92
43 Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. Arch Neurol 2010 1.91
44 Dietary factors and Alzheimer's disease. Lancet Neurol 2004 1.90
45 Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network. Clin Investig (Lond) 2012 1.90
46 Measures of adiposity and dementia risk in elderly persons. Arch Neurol 2007 1.88
47 Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease. Proc Natl Acad Sci U S A 2008 1.84
48 Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort. Arch Neurol 2010 1.80
49 Disparities in the recording of Parkinson's disease on death certificates. Mov Disord 2005 1.75
50 Health and function of participants in the Long Life Family Study: A comparison with other cohorts. Aging (Albany NY) 2011 1.74
51 Stroke and memory performance in elderly persons without dementia. Arch Neurol 2006 1.65
52 Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis. Nat Genet 2012 1.63
53 Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals. Arch Neurol 2010 1.61
54 Meta-analysis of the association between variants in SORL1 and Alzheimer disease. Arch Neurol 2011 1.59
55 Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proc Natl Acad Sci U S A 2013 1.58
56 Association between SORL1 and Alzheimer's disease in a genome-wide study. Neuroreport 2007 1.57
57 Association of shorter leukocyte telomere repeat length with dementia and mortality. Arch Neurol 2012 1.55
58 Late-life depression, mild cognitive impairment, and dementia. JAMA Neurol 2013 1.52
59 Imaging the Abeta-related neurotoxicity of Alzheimer disease. Arch Neurol 2007 1.49
60 Functional correlates and prevalence of mild parkinsonian signs in a community population of older people. Arch Neurol 2005 1.48
61 Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Hum Mol Genet 2012 1.46
62 Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease. Sci Transl Med 2014 1.45
63 Relationship between plasma lipids and all-cause mortality in nondemented elderly. J Am Geriatr Soc 2005 1.44
64 Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: implication of additional loci. Arch Neurol 2008 1.44
65 Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genet Med 2011 1.44
66 Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community. Arch Neurol 2012 1.44
67 The genetics of adult-onset neuropsychiatric disease: complexities and conundra? Science 2003 1.40
68 Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment. Arch Neurol 2005 1.39
69 Parkinsonian signs in older people in a community-based study: risk of incident dementia. Arch Neurol 2004 1.35
70 C9orf72 hexanucleotide repeat expansions in clinical Alzheimer disease. JAMA Neurol 2013 1.34
71 Investigation of c9orf72 in 4 neurodegenerative disorders. Arch Neurol 2012 1.32
72 Familial Alzheimer disease among Caribbean Hispanics: a reexamination of its association with APOE. Arch Neurol 2002 1.28
73 Parkinsonian signs in older people: prevalence and associations with smoking and coffee. Neurology 2003 1.27
74 Relation of higher folate intake to lower risk of Alzheimer disease in the elderly. Arch Neurol 2007 1.26
75 Meta-analysis of plasma amyloid-β levels in Alzheimer's disease. J Alzheimers Dis 2011 1.25
76 SORL1 is genetically associated with late-onset Alzheimer's disease in Japanese, Koreans and Caucasians. PLoS One 2013 1.23
77 Age-at-onset linkage analysis in Caribbean Hispanics with familial late-onset Alzheimer's disease. Neurogenetics 2007 1.22
78 Heritability estimates of endophenotypes of long and health life: the Long Life Family Study. J Gerontol A Biol Sci Med Sci 2010 1.22
79 Telephone assessment of cognitive function in the late-onset Alzheimer's disease family study. Arch Neurol 2010 1.22
80 Association of C-reactive protein with cognitive impairment. Arch Neurol 2010 1.19
81 Elevated plasma beta-amyloid peptide Abeta(42) levels, incident dementia, and mortality in Down syndrome. Arch Neurol 2007 1.19
82 Effect of smoking and time on cognitive function in the elderly without dementia. Neurology 2005 1.19
83 Linking hippocampal structure and function to memory performance in an aging population. Arch Neurol 2009 1.17
84 Metabolic syndrome and dementia risk in a multiethnic elderly cohort. Dement Geriatr Cogn Disord 2007 1.16
85 Impaired default network functional connectivity in autosomal dominant Alzheimer disease. Neurology 2013 1.16
86 TREM2 and neurodegenerative disease. N Engl J Med 2013 1.15
87 Telephone-based identification of mild cognitive impairment and dementia in a multicultural cohort. Arch Neurol 2011 1.15
88 Assessment and familial aggregation of psychosis in Alzheimer's disease from the National Institute on Aging Late Onset Alzheimer's Disease Family Study. Brain 2010 1.11
89 Olfactory identification deficits and MCI in a multi-ethnic elderly community sample. Neurobiol Aging 2008 1.10
90 Coding mutations in SORL1 and Alzheimer disease. Ann Neurol 2015 1.09
91 Both common variations and rare non-synonymous substitutions and small insertion/deletions in CLU are associated with increased Alzheimer risk. Mol Neurodegener 2012 1.08
92 ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology. Acta Neuropathol 2014 1.07
93 Relation of plasma lipids to all-cause mortality in Caucasian, African-American and Hispanic elders. Age Ageing 2008 1.07
94 Relation of plasma homocysteine to plasma amyloid beta levels. Neurochem Res 2006 1.06
95 Screening for C9ORF72 repeat expansion in FTLD. Neurobiol Aging 2012 1.05
96 Acquisition, recall, and forgetting of verbal information in long-term memory by young, middle-aged, and elderly individuals. Cortex 2003 1.04
97 Multiethnic genome-wide association study of cerebral white matter hyperintensities on MRI. Circ Cardiovasc Genet 2015 1.03
98 Plasma lipid levels in the elderly are not associated with the risk of mild cognitive impairment. Dement Geriatr Cogn Disord 2008 1.03
99 APOE and APOC1 promoter polymorphisms and the risk of Alzheimer disease in African American and Caribbean Hispanic individuals. Arch Neurol 2004 1.02
100 Initial assessment of the pathogenic mechanisms of the recently identified Alzheimer risk Loci. Ann Hum Genet 2013 1.02
101 Comparison of modifiable determinants of lipids and lipoprotein levels among African-Americans, Hispanics, and Non-Hispanic Caucasians > or =65 years of age living in New York City. Am J Cardiol 2002 1.01
102 Heritability of different forms of memory in the Late Onset Alzheimer's Disease Family Study. J Alzheimers Dis 2011 1.01
103 Genome-wide survey of large rare copy number variants in Alzheimer's disease among Caribbean hispanics. G3 (Bethesda) 2012 1.00
104 Onset of dementia is associated with age at menopause in women with Down's syndrome. Ann Neurol 2003 1.00
105 Heritability of and mortality prediction with a longevity phenotype: the healthy aging index. J Gerontol A Biol Sci Med Sci 2013 1.00
106 Analysis of an early-onset Parkinson's disease cohort for DJ-1 mutations. Mov Disord 2004 0.99
107 Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics. Arch Neurol 2006 0.98
108 Expanded genomewide scan implicates a novel locus at 3q28 among Caribbean hispanics with familial Alzheimer disease. Arch Neurol 2006 0.98
109 Analysis of copy number variation in Alzheimer's disease: the NIALOAD/ NCRAD Family Study. Curr Alzheimer Res 2012 0.97
110 Factor structure of parkinsonian signs in the community-dwelling elderly. Mov Disord 2004 0.95
111 Central obesity in the elderly is related to late-onset Alzheimer disease. Alzheimer Dis Assoc Disord 2012 0.94
112 Use of genetic variation as biomarkers for mild cognitive impairment and progression of mild cognitive impairment to dementia. J Alzheimers Dis 2010 0.93
113 Apolipoprotein E and familial longevity. Neurobiol Aging 2012 0.93
114 Preservation of cognitive and functional ability as markers of longevity. Neurobiol Aging 2004 0.92
115 Adiposity and Alzheimer's disease. Curr Alzheimer Res 2007 0.92
116 Relation between vascular risk factors and neuropsychological test performance among elderly persons with Alzheimer's disease. J Neurol Sci 2007 0.92
117 Depressive symptoms, antidepressant use, and brain volumes on MRI in a population-based cohort of old persons without dementia. J Alzheimers Dis 2012 0.92
118 The Saitohin 'Q7R' polymorphism and tau haplotype in multi-ethnic Alzheimer disease and Parkinson's disease cohorts. Neurosci Lett 2003 0.91
119 Cognitive function in families with exceptional survival. Neurobiol Aging 2011 0.91
120 Bioavailable estradiol and age at onset of Alzheimer's disease in postmenopausal women with Down syndrome. Neurosci Lett 2006 0.91
121 Possible association between SORL1 and Alzheimer disease? Reanalysing the data of Shibata et al. Dement Geriatr Cogn Disord 2008 0.89
122 Obesity enhances verbal memory in postmenopausal women with Down syndrome. Neurobiol Aging 2004 0.89
123 Dysexecutive versus amnestic Alzheimer disease subgroups: analysis of demographic, genetic, and vascular factors. Alzheimer Dis Assoc Disord 2013 0.89
124 C9ORF72 repeat expansions not detected in a group of patients with schizophrenia. Neurobiol Aging 2012 0.89
125 Impact of genetic variation in SORCS1 on memory retention. PLoS One 2011 0.88
126 Do gender, disability, and morbidity affect aging rate in the LLFS? Application of indices of cumulative deficits. Mech Ageing Dev 2011 0.88
127 Sex hormone binding globulin and incident Alzheimer's disease in elderly men and women. Neurobiol Aging 2008 0.87
128 Elevated sex-hormone binding globulin in elderly women with Alzheimer's disease. Neurobiol Aging 2004 0.86
129 The heritability of abstract reasoning in Caribbean Latinos with familial Alzheimer disease. Dement Geriatr Cogn Disord 2007 0.85
130 Analysis of copy number variation in Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. PLoS One 2012 0.83
131 Further examination of the candidate genes in chromosome 12p13 locus for late-onset Alzheimer disease. Neurogenetics 2008 0.83
132 Genetic variants in the Fat and Obesity Associated (FTO) gene and risk of Alzheimer's disease. PLoS One 2012 0.83
133 Course and etiology of dysexecutive MCI in a community sample. Alzheimers Dement 2013 0.82
134 Lobar microbleeds are associated with a decline in executive functioning in older adults. Cerebrovasc Dis 2014 0.82
135 Exceptional memory performance in the Long Life Family Study. Neurobiol Aging 2013 0.82
136 Effect of genetic variation in LRRTM3 on risk of Alzheimer disease. Arch Neurol 2012 0.82
137 Genetic influences on life span and survival among elderly African-Americans, Caribbean Hispanics, and Caucasians. Am J Med Genet A 2004 0.82
138 Reduced prevalence of cognitive impairment in families with exceptional longevity. JAMA Neurol 2013 0.81
139 Comparison of clinical manifestations in Alzheimer disease and dementia with Lewy bodies. Arch Neurol 2008 0.81
140 PLXNA4 is associated with Alzheimer disease and modulates tau phosphorylation. Ann Neurol 2014 0.81
141 White matter hyperintensity volume and impaired mobility among older adults. J Neurol 2012 0.80
142 Lessons from epidemiologic research about risk factors, modifiers, and progression of late onset Alzheimer's Disease in New York City at Columbia University Medical Center. J Alzheimers Dis 2013 0.80
143 Medicaid home care services and survival in New York City. Gerontologist 2005 0.80
144 Faster cognitive and functional decline in Dysexecutive versus amnestic Alzheimer's subgroups: a longitudinal analysis of the National Alzheimer's Coordinating Center (NACC) database. PLoS One 2013 0.79
145 Dissecting the relative influences of genes and the environment in Alzheimer's disease. Ann Neurol 2004 0.79
146 Association between variants in IDE-KIF11-HHEX and plasma amyloid β levels. Neurobiol Aging 2010 0.79
147 Use of genetic variation as biomarkers for Alzheimer's disease. Ann N Y Acad Sci 2009 0.79
148 A comparison of family history of psychiatric disorders among patients with early- and late-onset Alzheimer's disease. J Neuropsychiatry Clin Neurosci 2004 0.79
149 Vascular disease and cognitive impairment. Expert Rev Neurother 2008 0.79
150 Familial aggregation of dementia with Lewy bodies. Arch Neurol 2011 0.78
151 Brain traffic: subcellular transport of the amyloid precursor protein. Arch Neurol 2009 0.78
152 Alzheimer's disease research and development: a call for a new research roadmap. Ann N Y Acad Sci 2014 0.78
153 Brain drain: A bottom-up approach to normal pressure hydrocephalus. Ann Neurol 2010 0.78
154 No association of ALOX5AP polymorphisms with risk of MRI-defined brain infarcts. Neurobiol Aging 2011 0.76
155 Association studies between the plasmin genes and late-onset Alzheimer's disease. Neurobiol Aging 2006 0.76
156 Structural MRI Predictors of Late-Life Cognition Differ Across African Americans, Hispanics, and Whites. Curr Alzheimer Res 2015 0.76
157 Mediterranean diet and mortality in a US population. Arch Intern Med 2008 0.75
158 Different demographic, genetic, and longitudinal traits in language versus memory Alzheimer's subgroups. J Alzheimers Dis 2013 0.75
159 Role of p73 in Alzheimer disease: lack of association in mouse models or in human cohorts. Mol Neurodegener 2013 0.75
160 Erratum: The Rare-Variant Generalized Disequilibrium Test for Association Analysis of Nuclear and Extended Pedigrees with Application to Alzheimer Disease WGS Data. Am J Hum Genet 2017 0.75
161 The long and short of it: telomeres and the brain. Lancet Neurol 2006 0.75
162 Genetics and its use in Alzheimer's disease. Psychopharmacol Bull 2007 0.75
163 Genetic research and genetic testing in Alzheimer's disease: a view from the bridge. Nat Clin Pract Neurol 2007 0.75
164 Lewis P. Rowland, MD (1925-2017). Neurology 2017 0.75